Marco MaExecutive Director 北京
Ke (Marco) MA joined Northern Light Venture Capital in 2013. He had more than ten years’ experience in equity investment in the healthcare and life-science industry. Prior to joining Northern Light, Marco worked for Mountain View Partners, Jiangxi Copper Corporation International Investment (JCCII) and Kaiwu Capital as an investment professional. Marco also has the academic experience as an associate scientist at Chinese Academy of Medical Sciences.
Marco holds a MS in Biomedical Engineering from Peking Union Medical College and a BS in Pharmaceutical Engineering from Shandong University. He was also a visiting scholar at University of California San Diego.
Marco focuses on the sub-sectors as: digital healthcare, medical technology, medical service, etc. His portfolio companies includes: Connect Biopharma (NASDAQ: CNTB), CoyoteBio, OST Therapy, 66nao, Xynomic, DeepCyto, Wision AI, Quantapore, Novlead, Genepoint, Annoroad, etc.
- 2011Kaiwu Capital
- 2012 Mountain View Partners